Techno Medica Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	10,697	9,905	10,283	9,367	9,699	9,040
Revenue Growth (YoY)	3.79%	-3.68%	9.78%	-3.42%	7.29%	-7.85%
Cost of Revenue	5,598	4,978	5,131	4,738	4,882	4,586
Gross Profit	5,099	4,927	5,152	4,629	4,817	4,454
Selling, General & Admin	2,813	2,886	2,747	2,573	2,516	2,382
Research & Development	690	690	516	369	405	433
Operating Expenses	3,554	3,627	3,312	2,980	2,980	2,846
Operating Income	1,545	1,300	1,840	1,649	1,837	1,608
Interest & Investment Income	13.51	6	-	1	2	1
Currency Exchange Gain (Loss)	1.52	-15	2	-	6	4
Other Non Operating Income (Expenses)	11.59	12	27	17	5	17
EBT Excluding Unusual Items	1,572	1,303	1,869	1,667	1,850	1,630
Gain (Loss) on Sale of Assets	-	-	-9	-	-	-
Asset Writedown	-0.03	-	-	-2	-	-
Other Unusual Items	-165.56	16	-	-	-	19
Pretax Income	1,416	1,319	1,860	1,665	1,850	1,649
Income Tax Expense	378.19	315	512	515	569	496
Net Income	1,038	1,004	1,348	1,150	1,281	1,153
Net Income to Common	1,038	1,004	1,348	1,150	1,281	1,153
Net Income Growth	-8.03%	-25.52%	17.22%	-10.23%	11.10%	15.30%
Shares Outstanding (Basic)	7	7	8	8	8	8
Shares Outstanding (Diluted)	7	7	8	8	8	8
Shares Change (YoY)	0.54%	-11.17%	-7.64%	-0.64%	0.01%	0.04%
EPS (Basic)	149.70	144.99	172.93	136.26	150.81	135.75
EPS (Diluted)	149.70	144.99	172.93	136.26	150.81	135.75
EPS Growth	-8.07%	-16.16%	26.92%	-9.65%	11.09%	15.25%
Free Cash Flow	-	952	1,105	754	1,996	795
Free Cash Flow Per Share	-	137.48	141.76	89.34	234.98	93.60
Gross Margin	-	49.74%	50.10%	49.42%	49.66%	49.27%
Operating Margin	14.44%	13.13%	17.89%	17.60%	18.94%	17.79%
Profit Margin	9.70%	10.14%	13.11%	12.28%	13.21%	12.75%
Free Cash Flow Margin	-	9.61%	10.75%	8.05%	20.58%	8.79%
EBITDA	1,634	1,399	1,952	1,757	1,957	1,728
EBITDA Margin	-	14.12%	18.98%	18.76%	20.18%	19.11%
D&A For EBITDA	89.25	99	112	108	120	120
EBIT	1,545	1,300	1,840	1,649	1,837	1,608
EBIT Margin	-	13.13%	17.89%	17.60%	18.94%	17.79%
Effective Tax Rate	-	23.88%	27.53%	30.93%	30.76%	30.08%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.